Insider Transactions in Q1 2022 at Immunovant, Inc. (IMVT)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2022
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
19,227
-3.33%
|
$96,135
$5.9 P/Share
|
|
Mar 24
2022
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
6,381
-2.2%
|
$31,905
$5.9 P/Share
|
|
Jan 28
2022
|
Mark S. Levine Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
143,000
+50.0%
|
-
|
|
Jan 10
2022
|
Atul Pande Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,726
+25.97%
|
-
|
|
Jan 10
2022
|
Douglas J. Hughes Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,726
+21.32%
|
-
|
|
Jan 10
2022
|
George V Migausky Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,726
+19.63%
|
-
|
|
Jan 10
2022
|
Andrew J. Fromkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,726
+24.37%
|
-
|
|
Jan 10
2022
|
Frank Torti Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,126
+40.4%
|
-
|
|
Jan 07
2022
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
125,158
-17.8%
|
$876,106
$7.25 P/Share
|
|
Jan 07
2022
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
29,959
-14.79%
|
$209,713
$7.25 P/Share
|
|
Jan 07
2022
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
55,318
-16.04%
|
$387,226
$7.25 P/Share
|
|
Jan 05
2022
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
26,813
-11.96%
|
$214,504
$8.28 P/Share
|